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Abstract
Atopic dermatitis (AD) is characterized by allergic inflammation and itch. Thymic stromal
lymphopoietin (TSLP) is a pro-allergic cytokine implicated in AD. A paper in Cell transforms the
understanding of TSLP’s functional repertoire in general and in AD in particular showing that
TSLP can directly stimulate sensory neurons and provoke itch.
Atopic dermatitis (AD) is thought to develop as a consequence of impaired skin barrier
function and allergic inflammation in the skin. One of the most bothersome and even
debilitating aspects of AD is itch (pruritus). Itch in AD typically begets scratching, which
can in turn promote lesion formation and/or transformation to a chronic lichenified state.
Thus alleviating the unpleasant sensation of itch and the disease potentiating effects of
scratching are a goal of effective therapy in AD. Unfortunately, gaps in knowledge relating
to mechanisms of pruritus in AD often leads to suboptimal results for controlling this
symptom.
The pro-allergic cytokine TSLP is produced by a variety of epithelial cells, including
keratinocytes, as well as dendritic cells [1]. The TSLP receptor, a heterodimer of IL-7Rα
and TSLPR, is expressed on Th2 cells, dendritic cells, mast cells and type 2 innate lymphoid
cells. Keratinocyte-derived TSLP expression is increased in acute and chronic lesions in
patients with AD, while elevated TSLP is detected in airway epithelial cells in patients with
asthma. Moreover, genetic variants in TSLP are associated with the development of AD and
its most severe complications. Thus, the immunologic/inflammatory effects of TSLP in
allergic diseases are an area of intense investigation [1]. A recent paper in Cell by Wilson
and colleagues identifies a non-immunologic (neurostimulatory) effect of TSLP as a
pruritogen, an itch-inducing stimulus [2].
Wilson et al. demonstrated expression of TSLPR and IL-7Rα transcripts in mouse and
human dorsal root ganglion cells and localized TSLPR protein expression to a subset of
primary afferent nerve terminals in mouse skin [2]. Injection of TSLP into mouse cheek skin
induced scratching behavior in an IL-7Rα and primary afferent neuron-dependent manner.
TSLPR activation of primary afferent sensory neurons required the ion channel TRPA1 but
was independent of TRPV1 [2]. These data identify TSLP as a novel endogenous pruritogen
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and suggest that keratinocyte-derived TSLP may stimulate pruritus in AD and perhaps some
other dermatologic conditions.
In AD, barrier disruption impairs the function of protease inhibitors such as LEKT1 thus
favoring excessive activity of endogenous serine proteases like kallikrein 5 which in turn
cleave PAR2 leading to TSLP production by keratinocytes [3]. Using the aforementioned
mouse cheek injection model, Wilson et. al demonstrated that tryptase, another serine
protease implicated in AD triggered scratching behavior that was partially dependent on
IL-7Rα and PAR2 [2]. Additional studies showed that in vitro stimulation of keratinocytes
with PAR2 agonists triggered calcium influx and NFAT-dependent transcription of TSLP in
a manner dependent on the ion channel; similar findings were also noted in respiratory
epithelial cells [2].
To highlight the centrality of scratching in AD pathogenesis, AD is sometimes referred to as
the “itch that rashes”; in other words, the idea (while an oversimplification) is that patients
with AD scratch their pruritic skin, promoting lesion development and persistence (Figure
1A). The importance of peripheral nerves in cutaneous inflammation is highlighted by the
work of Ostrowski et al. showing attenuation of psoriasiform inflammation in KC-Tie2
transgenic mice that underwent surgical axotomy of cutaneous nerves [4]. The study by
Wilson et al. adds to the understanding of the function of the neuroimmune axis in the skin
by showing epithelial-derived TSLP can directly stimulate primary sensory neurons,
evoking robust itch/scratch behaviors in mice independent of lymphocytes and mast cells
[2]. Previously, Oyoshi et. al showed experimentally-induced epidermal injury and barrier
disruption by tape stripping promotes TSLP production in mouse skin [5]. Despite the strong
association between TSLP and Th2 responses, studies demonstrate that TSLP induced AD-
like skin phenotypes do not require lymphocytes or mast cells but rely on direct action of
TSLP on skin-resident group 2 innate lymphoid cells (ILC2) ([6]; Turner, unpublished
observation). Thus it is conceivable that TSLP drives the vicious itch-scratch cycle in AD as
an inducer of ILC2-mediated inflammation and pruritus and as a product of scratching
(Figure 1B).
Other immunomodulators may also act directly on primary sensory neurons in the skin to
stimulate pruritus. These include histamine from mast cells and the Th2 cell-derived
cytokine interleukin 31 (IL-31) [7]. Histamine-mediated stimulation of sensory neurons
triggers release of the immunomodulatory neuropeptides substance P and calcitonin gene
related peptide [8]. Whether TSLP or IL-31-mediated activation of sensory neurons triggers
release of neuropeptides or other immunomodulatory functions of neurons remains an open
question.
The proinflammatory effects of TSLP are thought to be important drivers of pathogenesis in
asthma, allergic rhinitis and other allergic diseases [1]. One of the models proposed to
explain the allergic march is based on the idea that keratinocytes-derived TSLP enters the
systemic circulation and acts in a systemic fashion on the developing immune system and
lung microenvironment predisposing children with AD to develop asthma. Local production
of TSLP by the respiratory epithelia may also directly contribute to the pathogenesis of
asthma and allergic rhinitis. Like the skin, the epithelium of the upper and lower respiratory
tract are innervated by sensory nerves [3]. Unlike TSLP-induced AD-like phenotypes,
however, TSLP-induced asthma-like airway inflammation relies on foreign antigens and
CD4+ T cells [9]. It remains to be determined if and how sensory neurons in the respiratory
tract respond to TSLP.
The discovery of TSLP as a pruritogen is transformative in that it establishes a non-
immunologic function for TSLP and suggests targeting TSLP in AD and perhaps other
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dermatologic conditions may be an effective way to treat some forms of pruritus. More
broadly, the work by Wilson et al. begs the question, what else does TSLP do? Does this
cytokine act elsewhere in the peripheral or central nervous or other cell populations beyond
the immune system, and if so, what effector function does it elicit? What is clear is that
much work remains to understand the biology of TSLP.
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Figure 1. TSLP bridging itch/scratch and AD progression
(A) Patients with AD scratch their pruritic skin promoting lesion formation and persistence.
This patient had extensive chronic lichenified AD of his left arm but relative sparing of the
right arm. These findings were attributed to the patient having left-sided hemiparesis
preventing him from scratching his right arm with his left hand, while being able to scratch
his left arm with his normally functioning right arm. Photo courtesy of Dr. Jeffrey B.
Travers, Department of Dermatology, Indiana University School of Medicine. (B) TSLP-
induced itch/scratch drives AD phenotypes without the involvement of lymphocytes or mast
cells. Scratch-caused epidermal injury and barrier disruption induce TSLP expression in
keratinocytes. TSLP stimulates directly the sensory neurons triggering itch and
subsequently, scratching behavior, and acts on skin-resident group 2 innate lymphoid cells
(ILC2) to induce IL-5 and IL-13 expression leading to eosinophil recruitment and
inflammation.
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